Ronald M. Baldwin

14.9k total citations · 2 hit papers
191 papers, 11.9k citations indexed

About

Ronald M. Baldwin is a scholar working on Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Ronald M. Baldwin has authored 191 papers receiving a total of 11.9k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Cellular and Molecular Neuroscience, 77 papers in Radiology, Nuclear Medicine and Imaging and 57 papers in Molecular Biology. Recurrent topics in Ronald M. Baldwin's work include Neuroscience and Neuropharmacology Research (60 papers), Medical Imaging Techniques and Applications (51 papers) and Neurotransmitter Receptor Influence on Behavior (50 papers). Ronald M. Baldwin is often cited by papers focused on Neuroscience and Neuropharmacology Research (60 papers), Medical Imaging Techniques and Applications (51 papers) and Neurotransmitter Receptor Influence on Behavior (50 papers). Ronald M. Baldwin collaborates with scholars based in United States, Canada and Switzerland. Ronald M. Baldwin's co-authors include Robert B. Innis, John Seibyl, Sami S. Zoghbi, Marc Laruelle, Dennis S. Charney, Yolanda Zea‐Ponce, Anissa Abi‐Dargham, Robert T. Malison, Paul B. Hoffer and Gilles Tamagnan and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Ronald M. Baldwin

189 papers receiving 11.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.

1996 980 citations Marc Laruelle, Sami S. Zoghbi et al. profile →
Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort

1998 628 citations John H. Krystal, Ronald M. Baldwin et al. American Journal of Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ronald M. Baldwin United States	54	6.1k	2.8k	2.7k	2.3k	2.2k	191	11.9k
S. John Gatley United States	51	6.5k 1.1×	3.4k 1.2×	2.4k 0.9×	3.0k 1.3×	1.0k 0.5×	130	11.7k
Mark Slifstein United States	57	5.6k 0.9×	3.3k 1.2×	2.3k 0.8×	2.5k 1.1×	812 0.4×	147	10.3k
Fritz A. Henn Germany	56	5.0k 0.8×	2.4k 0.9×	2.6k 0.9×	1.8k 0.8×	1.0k 0.5×	207	11.6k
Göran Sedvall Sweden	57	5.7k 0.9×	1.6k 0.6×	2.9k 1.1×	3.3k 1.4×	1.5k 0.7×	242	11.8k
Jarmo Hietala Finland	55	4.4k 0.7×	2.6k 0.9×	1.8k 0.7×	2.8k 1.2×	1.2k 0.6×	239	10.1k
Stephen L. Dewey United States	51	5.7k 0.9×	2.0k 0.7×	2.5k 0.9×	1.5k 0.6×	1.0k 0.5×	149	9.3k
Sami S. Zoghbi United States	61	6.1k 1.0×	1.8k 0.7×	3.6k 1.3×	2.3k 1.0×	2.5k 1.1×	271	14.2k
Paul M. Grasby United Kingdom	58	4.5k 0.7×	6.6k 2.4×	1.8k 0.7×	3.6k 1.5×	1.1k 0.5×	135	13.6k
Yu‐Shin Ding United States	47	3.8k 0.6×	2.6k 0.9×	1.7k 0.6×	2.4k 1.0×	792 0.4×	144	8.9k
Robert F. Dannals United States	69	6.8k 1.1×	3.0k 1.1×	4.9k 1.8×	2.5k 1.1×	1.4k 0.7×	360	17.9k

Countries citing papers authored by Ronald M. Baldwin

Since Specialization

Citations

This map shows the geographic impact of Ronald M. Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald M. Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald M. Baldwin more than expected).

Fields of papers citing papers by Ronald M. Baldwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald M. Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald M. Baldwin. The network helps show where Ronald M. Baldwin may publish in the future.

Co-authorship network of co-authors of Ronald M. Baldwin

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald M. Baldwin. A scholar is included among the top collaborators of Ronald M. Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald M. Baldwin. Ronald M. Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Treadway, Michael T., Joshua W. Buckholtz, Ronald L. Cowan, et al.. (2012). Dopaminergic Mechanisms of Individual Differences in Human Effort-Based Decision-Making. Journal of Neuroscience. 32(18). 6170–6176. 285 indexed citations

Barret, Olivier, David Thomae, David Alagille, et al.. (2012). First in vivo assessment of two PDE10 tracers [18F]MNI654 and [18F]MNI659. 53(1). 361–361. 9 indexed citations

Buck, Jason R., Eliot T. McKinley, Matthew R. Hight, et al.. (2010). Quantitative, Preclinical PET of Translocator Protein Expression in Glioma Using ¹⁸F-N-Fluoroacetyl-N-(2,5-Dimethoxybenzyl)-2-Phenoxyaniline. Journal of Nuclear Medicine. 52(1). 107–114. 51 indexed citations

Shah, Chirayu, Todd W. Miller, Shelby K. Wyatt, et al.. (2009). Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer. Clinical Cancer Research. 15(14). 4712–4721. 69 indexed citations

Manning, H. Charles, Nipun B. Merchant, John Virostko, et al.. (2008). Molecular Imaging of Therapeutic Response to Epidermal Growth Factor Receptor Blockade in Colorectal Cancer. Clinical Cancer Research. 14(22). 7413–7422. 82 indexed citations

Jones, Carrie K., Ashley E. Brady, Albert A. Davis, et al.. (2008). Novel Selective Allosteric Activator of the M₁Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats. Journal of Neuroscience. 28(41). 10422–10433. 203 indexed citations

Zhang, Ying, Zhaozhong Han, Martin W. Brechbiel, et al.. (2007). Radiation-guided anti-P-selectin antibody for tumor targeted imaging and therapy. Cancer Research. 67. 4187–4187.

Alagille, David, Ronald M. Baldwin, Bryan L. Roth, et al.. (2005). Functionalization at position 3 of the phenyl ring of the potent mGluR5 noncompetitive antagonists MPEP. Bioorganic & Medicinal Chemistry Letters. 15(4). 945–949. 30 indexed citations

Staley, Julie K., Gerard Sanacora, Gilles Tamagnan, et al.. (2005). Sex Differences in Diencephalon Serotonin Transporter Availability in Major Depression. Biological Psychiatry. 59(1). 40–47. 80 indexed citations

10.

Staley, Julie K., Christopher Gottschalk, Ismene L. Petrakis, et al.. (2005). Cortical γ-Aminobutyric Acid Type A–Benzodiazepine Receptors in Recovery From Alcohol Dependence. Archives of General Psychiatry. 62(8). 877–877. 35 indexed citations

11.

Kugaya, Akira, Gerard Sanacora, Julie K. Staley, et al.. (2004). Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors. Biological Psychiatry. 56(7). 497–502. 62 indexed citations

12.

Kugaya, Akira, Gerard Sanacora, Nicolaas P. L. G. Verhoeff, et al.. (2003). Cerebral benzodiazepine receptors in depressed patients measured with [123i]iomazenil SPECT. Biological Psychiatry. 54(8). 792–799. 52 indexed citations

13.

Dyck, Christopher H. van, Donald M. Quinlan, Julie K. Staley, et al.. (2002). Unaltered Dopamine Transporter Availability in Adult Attention Deficit Hyperactivity Disorder. American Journal of Psychiatry. 159(2). 309–312. 98 indexed citations

14.

Dyck, Christopher H van, Jair C. Soares, Julie K. Staley, et al.. (2000). Equilibrium modeling of 5-ht2a receptors with [18f]deuteroaltanserin and pet: feasibility of a constant infusion paradigm. Nuclear Medicine and Biology. 27(8). 715–722. 16 indexed citations

15.

Fujita, Masahiro, Gilles Tamagnan, Sami S. Zoghbi, et al.. (2000). Measurement of alpha4beta2 nicotinic acetylcholine receptors with [123I]5-I-A-85380 SPECT.. PubMed. 41(9). 1552–60. 35 indexed citations

16.

Cesati, Richard R., Gilles Tamagnan, Ronald M. Baldwin, et al.. (1999). Synthesis of cyclopentadienyl tricarbonyl technetium phenyl-tropane derivatives by direct double ligand transfer with ferrocene precursors. Journal of Labelled Compounds and Radiopharmaceuticals. 42. 1 indexed citations

17.

Laruelle, Marc, R. IYER, Mohammed S. Al‐Tikriti, et al.. (1997). Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse. 25(1). 1–14. 223 indexed citations

18.

Guez, David, J.P. Degaute, P L Malini, et al.. (1996). Traitement de l'hypertension arterielle par l'indapamide 1,5 mg comprime enrobé à libération prolongée: Synthèse des résultats. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 89. 17–25. 9 indexed citations

19.

Seibyl, John, Elizabeth A. Wallace, E. O. Smith, et al.. (1994). Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects.. PubMed. 35(5). 764–70. 38 indexed citations

20.

Innis, Robert B., et al.. (1991). SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves.. PubMed. 32(9). 1754–61. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact